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Abstract
The clinical use of decellularized cardiac valve allografts is increasing. Long-term data will be required to determine whether
they outperform conventional cryopreserved allografts. Valves decellularized using different processes may show varied
long-term outcomes. It is therefore important to understand the effects of speciﬁc decellularization technologies on the
characteristics of donor heart valves. Human cryopreserved aortic and pulmonary valved conduits were decellularized using
hypotonic buffer, 0.1% (w/v) sodium dodecyl sulfate and nuclease digestion. The decellularized tissues were compared to
cellular cryopreserved valve tissues using histology, immunohistochemistry, quantitation of total deoxyribose nucleic acid,
collagen and glycosaminoglycan content, in vitro cytotoxicity assays, uniaxial tensile testing and subcutaneous implantation
in mice. The decellularized tissues showed no histological evidence of cells or cell remnants and >97% deoxyribose nucleic acid
removal in all regions (arterial wall, muscle, leaﬂet and junction). The decellularized tissues retained collagen IV and von
Willebrand factor staining with some loss of ﬁbronectin, laminin and chondroitin sulfate staining. There was an absence of
major histocompatibility complex Class I staining in decellularized pulmonary valve tissues, with only residual staining in
isolated areas of decellularized aortic valve tissues. The collagen content of the tissues was not decreased following
decellularization however the glycosaminoglycan content was reduced. Only moderate changes in the maximum load to failure
of the tissues were recorded postdecellularization. The decellularized tissues were noncytotoxic in vitro, and were
biocompatible in vivo in a mouse subcutaneous implant model. The decellularization process will now be translated into a good
manufacturing practices-compatible process for donor cryopreserved valves with a view to future clinical use. Copyright ©
2016 The Authors Tissue Engineering and Regenerative Medicine published by John Wiley & Sons, Ltd.
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1. Introduction
Conventional heart valve replacements all have
limitations. Mechanical heart valve replacements can last
a life-time; however, patients with mechanical heart
valves require lifelong anticoagulation therapy.
Bioprosthetic heart valves suffer from limited durability
due to degeneration and calciﬁcation (Gao et al., 2004;
Senthilnathan et al., 1999). Neither mechanical nor
bioprosthetic heart valve replacements have the capacity
for growth in children or young developing adults.
Human donor cryopreserved allografts have low
thrombogenicity, superior hemodynamic performance
and resistance to infection; however, they fail to
regenerate in vivo and cannot grow and develop in the
recipient. They fail due to progressive degenerative
changes resulting from immunologically mediated
inﬂammation and calciﬁcation (Carr-White et al., 2001;
Hogan and O’Brien, 2003) and cardiac valve allografts
demonstrate accelerated degeneration and the need for
reoperation in children (Shaddy and Hawkins, 2002).
The pulmonary autograft switch operation is considered
the preferred option for children who require aortic valve
replacement (da Costa et al., 2009; Etnel et al., 2016) in
order to provide a living, functional aortic valve. A
cryopreserved pulmonary allograft is then placed in the
right ventricular outﬂow tract.
Since cryopreserved allogeneic heart valves contain
donor cellswith associated antigens that initiate an adverse
host response and act as foci for calciﬁcation (Baskett et al.,
2003; Dignan et al., 2003; O’Brien et al., 2001; Ryan et al.,
2006; Shaddy and Hawkins, 2002), it is logical to propose
that removal of the cellular components of allogeneic heart
valves prior to implantation would minimize the immune
response and calciﬁcation. Moreover, removal of donor
cells might also encourage repopulation with endogenous
cells capable of repair and remodelling, thus overcoming
the limitations of degeneration over time and producing
valves with the potential for growth in young patients,
eliminating the need for reoperation.
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Interest arose in the development of decellularized
heart valve allografts at the turn of the century. An antigen
reduction method process, the SynerGraft™ process was
developed by CryoLife Inc (Elkins et al., 2001a; O’Brien
et al., 1999) and Elkins et al. (2001a) were the ﬁrst to
report on very early clinical results of pulmonary allografts
treated by the SynerGraft process. This proprietary process
involves cell lysis induced by incubation in water and
nuclease digestion followed by a multiday isotonic
wash-out phase (Gerson et al., 2012; O’Brien et al.,
1999). Near complete removal of cells and cellular
components was demonstrated through histological and
immunocytochemical analysis with no corresponding
change in the in vitro biomechanics (Elkins et al.,
2001b). The CryoValve SG™ pulmonary valve has
subsequently been reported to perform well clinically in
the short to mid-term and outcomes in adults and
children with a mean follow-up of 4 years have been
comparable to (Bechtel et al., 2005, 2008; Brown et al.,
2010; Burch et al., 2010; Hawkins et al., 2003) or better
than (Konuma et al., 2009; Ruzmetov et al., 2012;
Tavakkol et al., 2005) conventional cryopreserved human
pulmonary allografts. The SynerGraft process has also
been applied to thicker human aortic valve conduits. At
1-year follow-up, small numbers of the valves showed
low transvalvular gradients and low panel speciﬁc
antibody responses (Zehr et al., 2005).
Decellularized human donor valve allografts produced
using different processes have also shown promise in
clinical studies despite a lack of detailed description of
the biological and biomechanical characteristics of the
valves in the literature. da Costa et al. (2009) reported
on good results in the Ross procedure (up to 4 years)using
pulmonary valves decellularized using low concentration
sodium dodecyl sulfate (SDS). Clinical studies of
decellularized aortic valve allografts showed stable
structural integrity, low rate of calciﬁcation and adequate
haemodynamics in the short to medium term (da Costa
et al., 2010). Up to 6 years’ follow-up, SDS decellularized
pulmonary allografts were associated with greater
freedom from reoperations compared to conventional
cryopreserved allografts (da Costa et al., 2014). In
Germany, the Haverich group have reported on the early
results of fresh pulmonary allografts decellularized using
0.5% (w/v) sodium deoxycholate and 0.5% (w/v) SDS
in children and young adults (Cebotari et al., 2011;
Neumann et al., 2014). In comparison to glutaraldehyde-
ﬁxed bovine jugular vein and cryopreserved allografts,
the decellularized fresh allografts showed improved
performance (Cebotari et al., 2011).
These studies indicate that decellularization processes
do not affect the in vivo performance of allogeneic heart
valves; however, longer-term data will be required to
determine whether they out-perform conventional
cryopreserved allografts and reduce or indeed eliminate
the need for reoperation. Importantly, since the
decellularized allografts that have been used clinically
have been produced using different processes, the
longer-term outcome may differ dependent upon the
speciﬁc decellularization process. It is therefore important
to understand the effects of speciﬁc decellularization
processes on the characteristics of allogeneic heart
valves.
In the UK, conventional cryopreserved human donor
valves are processed, stored and supplied to surgeons
through NHS Blood & Transplant Tissue & Eye Services
(NHS BT TES). With a view to improving clinical
performance, we have collaborated in the development
of robust decellularization processes for human donor
heart valves. A process for the decellularization of porcine
aortic and pulmonary roots was initially developed and
the biological and biomechanical characteristics of these
valves have been described (Booth et al., 2002; Korossis
et al., 2005; Luo et al., 2014; Wilcox et al., 2005).
Decellularized porcine aortic roots were shown to perform
well and demonstrated regenerative potential in the right
ventricular outﬂow tract of juvenile sheep over a 6-month
period (Paniagua Gutierrez et al., 2015). We have
subsequently applied our proprietary process to human
donor aortic and pulmonary valved conduits and here
we present a fully comprehensive description of the
process and biological characteristics of the decellularized
valved conduits.
2. Materials and methods
2.1. Human donor cryopreserved cardiac valves
The human donor aortic and pulmonary cardiac valves
used in this study were supplied by NHS BT TES, Speke,
Liverpool. The valves were found to be unsuitable for
therapeutic use but had full research and development
consent. Valves were cryopreserved using the standard
NHS BT TES process and stored at –80°C prior to use.
The study was conducted under UK NHS Health
Research Authority approval (REC 09/H1307/02). In
total, 26 aortic {14 male, 40 ± 9 years [± 95%
conﬁdence limits (CL)]; 12 female, 46 ± 8 years} and
26 pulmonary (14 male, 47 ± 11 years; 12 female;
48 ± 11 years) donated cardiac valves were used during
the course of these studies.
2.2. Decellularization process
Cryopreserved valved conduits were decellularized in
batches of four or six (half aortic; half pulmonary). All
steps of the process were carried out aseptically in a class
II microbiological safety cabinet. The bags containing
human cryopreserved valves were submerged in a water
bath at 37°C with gentle agitation for 9–12 min. The
outer and inner bags were cut open and the contents
were placed into a sterile 2-l beaker. The
cryopreservation solution was diluted by the sequential
addition of 200, 400 and 800 ml phosphate-buffered
saline wash solution [PBS plus 2.7 mM diaminoethane
tetra-acetic acid disodium salt (EDTA; VWR) and 10
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KIU/ml aprotinin (Nordic Pharma)] after 5, 10 and
15 min. The valves were placed in fresh (200 ml) wash
solution and left for 5 min before scraping the adventitial
layer of the valves with a scalpel. Each valve was then
sutured through the ventricular muscle and the distal
arterial wall to the base and neck of a 500-ml wide-
necked polypropylene bottle (Thermo Fisher Scientiﬁc
Ltd) using a 2.0 TI suture (Syneture) to ensure that the
valve lumen remained open during decellularization.
Subsequent wash steps were carried out using 8 ml/g
solution at 40–45°C with agitation [240 rotations/min
(rpm)] with the bottles laid horizontally unless otherwise
stated. Each valve was washed with three changes of PBS
wash solution for 5–15 min; hypotonic Tris buffer [10 mM
Tris (VWR), 0.1% (v/v) EDTA, 10 KIU/l aprotinin,
pH 8.0–8.2] for 24 h; 0.1% (v/v) SDS (Sigma–Aldridge)
in hypotonic Tris buffer for 24 h; PBS plus 10 KIU/l
aprotinin, for 2 × 5–15 min and then 24 h. The valves
were then incubated in nuclease solution (2–4 ml/g at
80 rpm) for 3 h at 37°C. This step was repeated. In initial
experiments the nuclease solution comprised 50 U/ml
deoxyribose nuclease (Pulmozyme, Roche), 1 U/ml
RNAse (Ribonuclease T1; Worthington), 10 mM MgCl2
in 50 mM Tris pH 7.5. This was subsequently replaced
with 10 U/ml Benzonase (Novagen) in 50 mM Tris,
1 mM MgCl2, pH 8.0–8.2.
The valves were then washed in PBS for 5–15 min
(twice) and 24 h, disinfected in Cambridge antibiotic
solution (Source BioScience; 80 rpm) for 3 h at 37°C,
washed again in PBS for 66 h and then in hypertonic
buffer (50 mM Tris, 1.5 M NaCl, pH 8.0–8.2) for 24 h
and PBS for 5–15 min (twice) and 24 h. Valves were
stored at 4°C in PBS and used for analyses within 1 week
or cryopreserved for biomechanical evaluation.
All decellularized conduits were subject to histology.
Initial batches produced using Pulmozyme as the
nuclease were analysed for total deoxyribose nucleic
acid (DNA), collagen and glycosaminoglycan (GAG)
content plus extract cytotoxicity tests. Subsequent
batches were produced using Benzonase as the nuclease
and these were used for contact cytotoxicity tests,
immunohistochemistry, in vivo biocompatibility in mice
and biomechanical analyses.
2.3. Histology and immunohistochemistry
Samples of cellular and decellularized valves were taken
longitudinally to incorporate half a leaﬂet, the junctional
region, artery wall and myocardial skirt, placed in
histology cassettes and ﬁxed in 10% (v/v) neutral buffered
formalin for 24 h, dehydrated and embedded in parafﬁn
wax. Serial sections (10 μm) were cut longitudinally at
two levels 120 μm apart. Sections from each level were
stained with haematoxylin and eosin (H&E) using
standard methods. Sections at each level were also stained
using 40,6-diamidino-2-phenylindole dihydrochloride
(DAPI; Sigma–Aldrich). The sections were rehydrated
and immersed in DAPI solution (1 mg/ml in 10 mM Tris,
1 mM Na2EDTA, 1 mM NaCl pH 7.4) for 10 min, washed
in PBS and mounted in ﬂuorescence mounting medium
(Dako) to detect residual double stranded DNA in the
tissues. Von Kossa staining of sections was used to visualize
calcium and performed as follows. Sections were
immersed in 1% (w/v) silver nitrate (Sigma) for 1 h on a
light box and then washed in sodium thiosulfate
(158 mM; VWR) for 5 min, washed in distilled water and
then counterstained in fast red (0.1% w/v nuclear fast
red (Sigma) 5% w/v aluminium sulfate (Thermo Fisher).
Immunolabelling was carried out using an Envision
detection system (Thermo Scientiﬁc). Rabbit polyclonal
antibodies to von Willebrand factor (VWF; 1:200; Dako
A0082) and ﬁbronectin (1:100; Dako A0245) and mouse
monoclonal antibodies to chondroitin sulfate (1:200;
Sigma CS-56 IgM), collagen IV (1:50; Dako CIV22
IgG1), laminin (1:800; Sigma LAM-89; IgG1) and rabbit
monoclonal to HLA-A (1:30; Abcam EP1395Y) were used
to determine the retention/removal of extracellular
matrix (ECM) and membrane proteins following
decellularization. For detection of VWF and collagen IV,
microwave antigen retrieval was used (10 mM citric acid
pH 6.0 for 10 min). For detection of ﬁbronectin,
chondroitin sulfate and laminin, trypsin antigen retrieval
was carried out by incubating in 0.1% (w/v) trypsin in
0.1% (w/v) CaCl2 at a pH of 7.8 for 10 min at 37°C.
Appropriate isotype control antibodies and omission of
the primary antibodies served as a negative controls.
Images were captured using an upright Olympus BX51
light and ﬂuorescence microscope ﬁtted with a DAPI ﬁlter,
Olympus XC50 digital camera and Cell B software
(Olympus®, UK).
2.4. Total DNA extraction and quantiﬁcation
DNA was extracted from four areas of cellular and
decellularized aortic and pulmonary roots (n = 3 or 4;
leaﬂet, artery wall, myocardial skirt and the junction of
the leaﬂet to the wall) using a QIAamp DNA mini kit
(Qiagen). DNA was extracted from 25 mg of cellular
tissues and 80–250 mg of decellularized tissues. Extracted
DNA was quantiﬁed using a nanodrop spectrophotometer
at 260 nm (Thermo Fisher Scientiﬁc).
2.5. Biochemical assays
Triplicate samples of the arterial wall tissue (~200 mg)
and one leaﬂet (~25 mg) from three cellular and three
decellularized aortic and pulmonary roots were ﬁnely
macerated and lyophilized to constant weight.
2.5.1. Hydroxyproline assay
Hydroxyproline content was used as a measure of total
collagen content. Lyophilized samples were hydrolyzed
in 6 M HCl for 4 h at 120°C and 103.4 KPa. The hydrolyzed
solutions were neutralized with 6 M NaOH. Diluted
samples of the hydrolyzed tissue samples were assayed
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as described by Luo et al. (2014). The hydroxyproline
content of the samples was determined by interpolation
from a standard curve of trans-4-hydroxy-L-proline
concentration against absorbance at 570 nm.
2.5.2. GAG assay
Lyophilized samples were incubated with 5 ml of papain
(50 U/ml (Sigma); in PBS plus 5 mM cysteine-HCl (Sigma)
and 5 mM EDTA; pH 6.0) for 42 h at 60°C. Digested tissue
samples (40 μl) were mixed with 250 μl 1,9 dimethylene
blue (Sigma) dye solution [1.6% (w/v) in 0.5% (v/v)
ethanol (VWR), 0.2% (v/v) formic acid (Sigma), 0.2%
(w/v) sodium formate (VWR); pH 3.0]. Optical densities
were determined after 1 min using a microplate
spectrophotometer at 525 nm. The GAG content was
measured by interpolation from a standard curve of
chondroitin sulfate B concentration against absorbance.
2.6. In vitro cytotoxicity assays
Extract and contact cytotoxicity tests were carried out
using 3 T3 murine ﬁbroblasts and baby hamster kidney
(BHK) cells (BHK 21 Strain 31, ECACC). 3 T3 cells were
cultured in Dulbecco’s modiﬁed Eagle’s medium (MEM;
Sigma) plus 10% (v/v) fetal bovine serum (Sera Lab),
100 U/ml penicillin, 100 μg/ml streptomycin (Sigma),
and 2 mM L-glutamine (Sigma). BHK cells were cultured
in Glasgow’s MEM (Sigma) containing 5% (v/v) FBS,
2.5% (v/v) tryptose phosphate broth (Oxoid) plus
100 U/ml penicillin, 100 g/ml streptomycin, 2 mM L-
glutamine at 37°C in 5% (v/v) CO2 in air.
For extract tests, triplicate samples of macerated
decellularized aortic (n = 4) and pulmonary wall tissues
(n = 4) were incubated in Dulbecco’s MEM or Glasgow’s
MEM (100 mg tissue per ml) for 72 h with agitation and
centrifuged at 600 × g for 15 min. The supernatants were
checked for sterility prior to addition to cell cultures. 3 T3
(1.25 × 105/ml) and BHK (5 × 104/ml) cells were seeded
(200 μl) into 96-well plates and incubated for 16 hours at
37°C in 5% (v/v) CO2 in air. The culture medium was
removed and replaced with 100 μl of fresh medium with
double concentration supplements plus 100 μl of the
tissue extract. The controls comprised 200 μl of 40% (v/
v) dimethyl sulfoxide (DMSO; Sigma) in culture medium
(positive) or culture medium alone (negative). The cells
were cultured for 48 h and the adenosine triphosphate
(ATP) content of the cells determined using the ATP
Lite-M® assay (Packard) according to the manufacturer’s
instructions. Data were recorded as luminescent counts/s.
For the contact assay, triplicate samples of decellularized
aortic and pulmonary wall (4–5 × 2–3 mm; n = 3) were
attached to the bottoms of six-well culture plates using
collagen gel (extracted from rat tails). 3 T3 or BHK cells
(2 ml) were seeded into each well at 2 × 105/ml.
Cyanoacrylate glue was used as the positive control,
collagen gel and cells alone were used as the negative
controls. Plates were incubated at 37°C in 5% (v/v) CO2
in air for 48–72 h (approximately 80% conﬂuence). The
plates were then viewed by phase contrast microscopy to
assess whether the cells grew up to and in contact with
the tissue with normal cellular morphology.
2.7. Subcutaneous implantation in mice
The response to cellular and decellularized aortic and
pulmonary wall and leaﬂet tissues was assessed using a
mouse subcutaneous implant model. Samples of tissues
(3 × 3 mm; 1 per mouse) were implanted subcutaneously
along the mid-dorsal line of C3H mice (female; 4–6 weeks
old; Harlan). Mice were fed food and water ab libitum,
monitored and weighed weekly for a period of 3 months.
Mice were then humanely sacriﬁced, and the implanted
tissues retrieved for analysis. All animal procedures were
carried out under appropriate UK Home Ofﬁce licenses.
The explanted tissues together with the surrounding
skin were ﬁxed in 10% (v/v) neutral buffered formalin
for 24 h, processed into parafﬁn wax blocks and H&E
stained tissue sections were used to determine cell
inﬁltration and morphology. The sections were viewed
and scored by two independent observers. The thickness
of the capsule surrounding the explanted tissue was
determined by taking six measurements (Image Pro Plus®
imaging software; Media Cybernetics) at predetermined
locations along the circumference of the tissue explants.
The cellular response to the implanted tissues was assessed
at six predetermined locations around the periphery of the
implants and the number of polymorphonuclear cells
(PMNs), mononuclear phagocytes and lymphocytes per
40× ﬁeld of view assessed using a scale of 0–4 (0 = no
cells; 1=1–5 cells; 2=5–10 cells; 3= heavy; 4= packed).
The total number of giant cells was recorded and the
overall degree of cellular inﬁltration into the implants
was assessed alongside the extent of calciﬁcation and
necrosis as slight, moderate, marked or heavy.
2.8. Uniaxial tensile tests
Uniaxial tensile tests were conducted on cellular
cryopreserved aortic (n = 8) and pulmonary (n = 4)
valve and decellularized aortic (n = 4) and pulmonary
(n = 4) valve tissues from conduits that had been
cryopreserved again postdecellularization. This was to
mimic the means by which the conduits would be
preserved postdecellularization. Root wall and leaﬂet
specimens from all the cellular and decellularized valves
were subjected to uniaxial tensile testing to failure using
an Instron 3365 (Instron® Corporation) ﬁtted with a
50 N load cell at 10 mm/min under hydrated conditions
in PBS at 37°C. Tissue specimens with 10 mm gauge
length and 5 mmwidth were prepared from the valve root
wall in the axial and circumferential directions from each
valve, and from the valve leaﬂet in the circumferential
direction. Due to size limitations, the radial specimens
from valve leaﬂets were 3 mm in width with a 6 mm
gauge length. Each tissue specimen thickness was
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measured with a digital thickness gauge J-40 V, having a
precision of 0.01 mm. The measured load was plotted
against the extension and maximum load was recorded
for all tissue specimens.
2.9. Data analysis
The Student t test was used for comparison of groups of
two means and one-way analysis of variance (ANOVA) was
used for the comparison of data from more than two
groups. Following ANOVA, individual differences between
group means were calculated using the T-method to
determine the minimal signiﬁcant difference (p < 0.05).
3. Results
3.1. Histological and immunohistochemical assessment of
cellular and decellularized tissues
H&E-stained sections of cellular tissues showed the cell
distribution throughout the aortic and pulmonary root
(Figure 1). The media layer of the aortic arterial wall
was markedly thicker than that of the pulmonary artery
wall, which appeared less organized (Figure 1). The
junctional region is the area of the tissue where the root
of the valve leaﬂet attaches to the ventricular muscle
and arterial wall as illustrated for the aortic valve in
Figure 1. DAPI stained sections of the cellular tissues
showed the distribution of cell nuclei within the arterial
wall and muscle/ junction regions with sparser numbers
of cell nuclei within the cellular leaﬂet tissues (Figure 1).
Sections of the decellularized aortic and pulmonary
valve tissues showed no evidence of cells or cell nuclei
when stained with H&E. Representative sections of the
aortic valve arterial wall, ventricular muscle and leaﬂet
(Figure 1) together with images of sections of the
pulmonary valve arterial wall, junctional region and
leaﬂet (Figure 1) showed that the histoarchitecture of
both the aortic and pulmonary valves was well preserved
following decellularization. DAPI stained sections showed
no evidence of cell nuclei within the decellularized
tissues (Figure 1).
Sections of cellular and decellularized aortic and
pulmonary valve tissues were stained with antibodies to
extracellular matrix proteins and representative images
are shown in Figure 2. The degree of staining was
Figure 1. Images of H&E and DAPI stained sections of cellular cryopreserved and decellularized aortic and pulmonary valved conduit tissues. H&E-stained sections of the cellular
arterial wall components of the aortic and pulmonary valved conduits show the cellular distribution in the intimal (I), medial (Me) and adventitial (A) regions. The junctional region is the
area where the arterial wall (W), muscle (M) and leaﬂet (L) merge. The trilaminar structure of the cellular leaﬂet tissues is clearly visible with the ﬁbrosa (F), spongiosa (S) and ventricularis
(V) layers in the aortic and pulmonary leaﬂets. DAPI stained sections of the cellular tissues show the cell distribution in the arterial wall, muscle and leaﬂets, with sparser cells in the leaﬂet
tissues. Sections of the decellularized aortic and pulmonary valve tissues show no evidence of cells or cell nuclei when stained with H&E or DAPI and show that the histoarchitecture of both
the aortic and pulmonary valve tissues is well preserved following decellularization. Scale bars are 200 μm unless otherwise labelled [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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qualitatively graded on a scale of 0–5 in the arterial wall
and leaﬂet tissues and the results are summarized in
Table 1. There was good retention of collagen IV and
VWF staining in the basement membrane of the tissues
following decellularization and some loss of intensity of
ﬁbronectin, laminin and chondroitin sulfate staining in
the tissues following decellularization.
Immunohistochemical staining for major
histocompatibility complex (MHC) Class I showed
expression of MHC Class I by the majority of cells in the
cellular tissues (Figure 2). Following decellularization
there was an absence of MHC Class I staining in the
pulmonary valve arterial wall and leaﬂet tissues, with
some evidence of residual staining in isolated areas of
the decellularized aortic wall and leaﬂet tissues
(Figure 2; Table 1).
3.2. Total DNA content
Total DNA content (per wet tissue weight) of the cellular
and decellularized tissues is presented in Table 2. The
DNA content of cellular valve tissues ranged from
211 ng/mg (pulmonary valve junction) to 618 ng/mg
(aortic valve ventricular muscle). The DNA content of
the cellular valve tissues showed a high degree of
variation, however, overall the DNA content was greatest
in the ventricular muscle and lowest in the leaﬂets and
junctional regions. Following decellularization the DNA
content was <10 ng/mg for all tissues except for the
pulmonary leaﬂet (19.7 ng/mg). For all other
decellularized tissues, the DNA content was reduced to
<3% of the cellular tissues.
Figure 2. Immunohistochemical analysis of sections of cellular cryopreserved and decellularized aortic and pulmonary valved conduit tissues. Images of sections of cellular and
decellularized aortic valve leaﬂet tissue stained with antibodies to collagen IV and MHC Class I show retention of collagen IV in the intimal basement membrane (arrows) and loss of MHC
Class I immunostaining following decellularization. Images of sections of cellular and decellularized aortic wall tissue stained with antibodies to ﬁbronectin and laminin show a reduction of
ﬁbronectin and laminin (both cell adhesion proteins) postdecellularization. Images of sections of cellular and decellularized pulmonary wall tissues show a reduction in chondroitin sulfate
(Chond S; representative of GAGs) and VWF following decellularization. Scale bars 200 μm unless otherwise labelled [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
Table 1. Qualitative assessment of immunohistochemical staining of sections of
cellular and decellularized aortic and pulmonary valve tissues. Sections of tissues
stained with antibodies to the extracellular matrix components were graded on a scale
of – (no staining) to +++++ (intense staining). Collagen IV was graded in the matrix
plus basement membrane of the wall tissues and the basement membrane of the leaﬂets,
according to where it was expressed. MHC Class 1 was graded on cells in cellular tissue. A
grade of ± in the decellularized tissue indicates isolated residual staining
Collagen
IV
Fibronectin VWF Laminin Chondroitin
sulfate
MHC
Class I
Aortic valve
Wall Cellular +++ +++++ ++ ++ +++ ++
Decelled ++ ++++ ++ + ++ ±
Leaﬂet Cellular ++ +++ + + ++ ++
Decelled ++ +++ + ± ++ ±
Pulmonary valve
Wall Cellular +++ ++++ ++ + +++ ++
Decelled ++ ++ ++ ± ++ –
Leaﬂet Cellular ++ ++ + + +++ ++
Decelled ++ ++ + ND ++ –
ND = not done.
Table 2. Total DNA in cellular and decellularized aortic and pulmonary valve tissues and percentage remaining after decellularization. The total DNA was extracted from three
samples of tissues from each of four areas (leaﬂet, wall, junction and muscle) of three cellular aortic, four decellularized aortic, three cellular pulmonary and four decellularized
pulmonary valves and quantiﬁed by nanodrop spectrometry
Total DNA ng/mg ± 95% CL % DNA in
decellularized
Total DNA ng/mg ± 95% CL % DNA in
decellularized
Cellular Decellularized Cellular Decellularized
Aortic Leaﬂet 231 ± 246 5.9 ± 4.8* 2.5% Pulmonary Leaﬂet 298 ± 321 19.7 ± 16.6* 6.5%
Wall 294 ± 268 3.0 ± 0.9* 1.0% Wall 316 ± 226 2.3 ± 0.9* 0.7%
Junction 214 ± 259 2.1 ± 2.2* 1.0% Junction 211 ± 248 6.1 ± 0.7* 2.9%
Muscle 618 ± 1253 2.1 ± 0.9 0.3% Muscle 460 ± 333 3.4 ± 5.4* 0.7%
The total DNA content is presented as the mean (n = 3 or 4) ± 95% CL. The data for each type of tissue before and after decellularization was analysed by Student t test, which revealed
a signiﬁcant reduction in DNA levels for all tissues (*p < 0.05) with the exception of the aortic valve muscle tissue (p= 0.08). The percentage DNA remaining after decellularization was
determined from the mean values for each region of tissue.
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3.3. Hydroxyproline and GAG content
The total collagen content of the cellular and
decellularized cardiac valve arterial wall and leaﬂet tissues
(Table 3) was assessed by determination of the
hydroxyproline content and then multiplying the value
by 7.14 (Neuman and Logan, 1950). The collagen content
of the arterial wall of the cellular aortic and pulmonary
valves was similar (324 and 319 μg/mg respectively) and
this did not change signiﬁcantly following
decellularization. The collagen content of the cellular
aortic and pulmonary valve leaﬂets was higher (511 and
554 μg/mg respectively) and the collagen content of both
types of leaﬂet tissue increased signiﬁcantly following
decellularization (736 and 765 μg/mg respectively). The
GAG content of the cellular aortic valve tissues (Table 3;
10.5 μg/mg wall; 11.4 μg/mg leaﬂet) was slightly greater
than the GAG content of the pulmonary valve tissues
(6.6 μg/mg wall; 8 μg/mg leaﬂet). Following
decellularization, the GAG content of the conduit wall
tissues was reduced by 34% (aortic) and 40%
(pulmonary), although this was only signiﬁcant for the
pulmonary artery tissues (Student t test; p=0.008). There
was a signiﬁcant and marked decrease of 75% (aortic) and
74% (pulmonary) in the GAG content of the decellularized
valve leaﬂets compared to cellular tissues (Table 3).
3.4. In vitro cytotoxicity testing
In order to determine whether the decellularized tissues
were cytocompatible, extract and contact cytotoxicity tests
were carried out using arterial wall tissues (Figure 3).
Table 3. Total collagen and glycosaminoglycan content of cellular and
decellularized aortic and pulmonary valve tissues. The total collagen and
glycosaminoglycan (GAG) content of the arterial wall and leaﬂet tissues of three
cellular aortic and pulmonary valves and three decellularized aortic and pulmonary
valves was quantiﬁed
Cellular μg/mg Decellularized μg/mg p
Collagen
Aortic valve Wall 323.59 ± 112.23 402.28 ± 115.89 0.104
Leaﬂet 511.15 ± 186.2 735.69 ± 254.68 0.038*
Pulmonary valve Wall 318.70 ± 118.82 398.76 ± 107.86 0.099
Leaﬂet 553.57 ± 190.32 764.71 ± 90.22 0.013*
GAGs
Aortic valve Wall 10.49 ± 6.56 6.93 ± 5.4 0.145
Leaﬂet 11.36 ± 0.39 3.94 ± 3.1 0.001*
Pulmonary valve Wall 6.57 ± 2.21 3.93 ± 0.6 0.008*
Leaﬂet 7.98 ± 2.83 2.89 ± 1.5 0.002*
The total collagen and GAG content are presented as the mean (n = 3) ± 95% CL. The
data for each tissue type before and after decellularization were analysed using the
Student t test, which revealed a signiﬁcant increase in collagen content of decellularized
aortic and pulmonary valve leaﬂets and a signiﬁcant decrease in GAG content of aortic
valve leaﬂets and pulmonary valve leaﬂets and wall tissue following decellularization.
Figure 3. Extract and contact cytotoxicity assays of decellularized aortic and pulmonary artery wall tissues. ATP levels of BHK cells (a) and 3 T3 cells (b) following 48 h culture with
decellularized tissue extracts. Data are presented as the mean (n = 3) luminescent counts/s (CPS) ± 95% CL. NC negative control (cells with no extract); PC positive control (40% DMSO);
A1–A4 aortic wall extracts; P1–P4 pulmonary wall extracts. Data were analysed by one-way analysis of variance for each cell line. This showed no signiﬁcant difference in the mean ATP
levels in the presence of the extracts compared to cells cultured in medium alone. There was a signiﬁcant difference (* p < 0.05) in the ATP levels of the positive control (DMSO) compared
to all other groups for both 3 T3 and BHK cells. (c) Phase contrast microscopy images of BHK cells (top panel) and 3 T3 cells (bottom panel) growing in contact with aortic wall tissue (AW)
and pulmonary wall tissue (PW) but not the positive control (PC) of cyanoacrylate. NC cells cultured alone [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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There were no signiﬁcant difference between the ATP
levels of BHK (Figure 3a) or 3 T3 cells (Figure 3b) cultured
for 48 h in the presence of the decellularized tissue
extracts compared to the cell lines cultured in medium
alone (ANOVA). The positive control of 40% DMSO
signiﬁcantly reduced (p < 0.05; ANOVA) the ATP content
of both 3 T3 and BHK cells following 48 h of culture.
Similarly, the decellularized tissues showed no evidence
of toxicity when cultured in contact with 3 T3 or BHK cells
(Figure 3c). The cells grew up to and in contact with the
tissues and showed no evidence of change in morphology
compared to the cells cultured alone on tissue culture
plastic. The positive control of cyanoacrylate clearly killed
the cells in close proximity in culture.
3.5. In vivo biocompatibility
In initial studies, samples of cellular and decellularized
aortic and pulmonary valve leaﬂet and wall tissues, each
from three donors were implanted in mice and left in situ
for 12 weeks. Upon explantation, the tissues were
analysed using histology. Despite evidence that the
decellularized tissues had integrated and had been
recolonized by host cells, there was evidence of
calciﬁcation in a proportion of the decellularized
explanted tissue samples (Figure 4). A review of age of
donors of these decellularized valves [mean ± standard
deviation (SD) 58 ± 6 years; 3 females] and retrospective
analysis of remaining samples of the implanted
decellularized tissues by von Kossa staining (Figure 4)
suggested that residual calcium in the decellularized
valve tissues exacerbated this reaction.
The study was repeated using valves from donors of a
younger age. Four pulmonary valves (mean ± SD age
26±8 years; threemale, one female) and two aortic valves
(35 and 36 years; female) were selected. Prior to
decellularization, a sample of the distal portion of the
arterial wall of each valve was taken and divided into two
for (a) implantation in mice (cellular tissue) and (b)
histological evaluation with H&E and von Kossa staining.
The remainder of each valve was then decellularized,
dissected longitudinally into three portions (including
wall, leaﬂet and ventricular muscle). One portion was
subject to histological evaluation and samples of the
remaining tissues were implanted in mice. Histological
staining of the cellular valve arterial wall prior to
decellularization revealed spots of calciﬁcation in the
aortic valve wall tissues, with fewer spots in the pulmonary
wall tissues. Following decellularization there was no
evidence of any remaining calcium deposits in the wall or
leaﬂet tissues and the histology conﬁrmed successful
decellularization. Samples of the cellular arterial wall,
decellularized arterial wall and decellularized leaﬂet
tissues (n = 4; 1 per donor valve for pulmonary and 2,
one from each remaining portion of donor valve for aortic)
were implanted into mice and left in situ for 12 weeks.
Upon explantation the tissues were analysed using
histology. The results are presented in Figure (5).
The explanted cellular aortic and pulmonary arterial
wall tissues were surrounded by a capsule of cells which
were predominantly macrophages with only occasional
lymphocytes, PMNs and giant cells. Very few cells had
inﬁltrated into the central areas of the implanted tissues,
which showed areas of calciﬁcation and tissue
deterioration (Figure 5). In contrast the explanted
decellularized aortic and pulmonary arterial wall tissues
were not surrounded by thickened capsules of cells, but
rather high densities of cells inﬁltrated the peripheral
regions of the implants (Figure 5). Moreover, cells were
observed penetrating the central regions of the implanted
decellularized wall tissues. The cells in the peripheral
regions of the implants were predominantly macrophages
with only occasional lymphocytes, PMNs and giant cells.
There was little evidence of tissue calciﬁcation or
deterioration. The decellularized pulmonary and aortic
valve leaﬂet tissues were biocompatible in the mouse
model (Figure 5) with little evidence of ﬁbrous capsule
development and cells had inﬁltrated into the central
areas of the implants. Again, the cells in the peripheral
regions of the implants were predominantly macrophages
with only occasional lymphocytes, PMNs and giant cells.
The semiquantitative histopathological analysis of the
implanted tissues is presented in Figure 6. This analysis
Figure 4. Images of sections of explanted decellularized aortic and pulmonary valve leaﬂets from initial in vivo study in mice stained with H&E and von Kossa stained image of
nonimplanted pulmonary valve tissue. Samples of decellularized tissues were implanted subcutaneously in mice for 12 weeks. The explanted acellular aortic leaﬂet tissue showed good
biocompatibility and integration. The explanted decellularized pulmonary leaﬂet tissue showed good biocompatibility and integration with a focal area of calciﬁcation (arrow). Von Kossa
staining of sections of non-implanted decellularized pulmonary leaﬂet tissue showed the presence of calcium (arrows). Scale bars 200 μm [Colour ﬁgure can be viewed at
wileyonlinelibrary.com]
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revealed no obvious differences in the nature of the
cellular inﬁltrate in the peripheral regions of the
implanted cellular vs. decellularized tissues. There were,
however, marked differences in the grades for
calciﬁcation and cellular inﬁltration into the central
regions of the implants. The cellular arterial wall tissues
showed marked calciﬁcation and slight cellular ingrowth
whilst the matched decellularized arterial wall tissues
showed no to slight calciﬁcation and moderate to marked
cellular ingrowth. The capsule surrounding the cellular
arterial wall tissues was notably thicker than the capsule
surrounding the decellularized arterial wall tissues
although this was only signiﬁcant (p = 0.03; Student t
test) for the aortic wall tissue. The decellularized leaﬂet
tissues showed marked cellular ingrowth with an absence
of overt calciﬁcation and capsule formation.
3.6. Biomechanical assessment of decellularized tissues
The maximum load for the cellular and decellularized
aortic and pulmonary valve tissues was determined from
the uniaxial tensile tests and is detailed in Table 4. There
was no signiﬁcant difference (p > 0.05) in the mean
maximum load between the cellular and decellularized
tissues for axial and circumferential aortic wall specimens,
radial aortic leaﬂet specimens, and circumferential
pulmonary wall and leaﬂet specimens. However, a
signiﬁcant increase in mean maximum load for the
decellularized aortic leaﬂet specimens in the
circumferential direction was observed (p < 0.05). Also
the mean maximum load for the axial decellularized
pulmonary wall specimens and the radial decellularized
pulmonary leaﬂet specimens was signiﬁcantly reduced
(p < 0.05).
4. Discussion
In this study, a successful decellularization process
developed for porcine aortic and pulmonary valves (Luo
et al., 2014; Wilcox et al., 2005) was transferred to human
donor valved roots with a view to manufacturing
decellularized cardiac valves for clinical use.
Cryopreserved cardiac valved conduits that were
Figure 5. Images of sections of explanted cellular and decellularized aortic and pulmonary valve tissues (stained with H&E) 12 weeks after subcutaneous implantation in mice.
Samples of cellular and decellularized aortic and pulmonary artery tissues from the same valved conduits were implanted subcutaneously in mice for 12 weeks. Both the cellular aortic and
pulmonary artery show evidence of capsule formation, limited cell inﬁltration and areas of calciﬁcation and tissue deterioration. The explanted decellularized aortic and pulmonary arterial
wall tissues show high numbers of cells inﬁltrating the peripheral regions of the implants with cells penetrating the central regions and little evidence of tissue calciﬁcation or deterioration.
Samples of decellularized pulmonary and aortic valve leaﬂet tissues implanted subcutaneously in mice for 12 weeks were fully inﬁltrated with cells with no evidence of tissue deterioration or
calciﬁcation. Black arrows indicate mouse epidermis. White arrows indicate areas of calciﬁcation. Occasional black spots are sectioned mouse hair. Scale bars 200 μm unless otherwise
labelled [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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unsuitable for clinical application were used since it was
impractical to use freshly harvested tissue for the
purposes of this study. For porcine valves, the process
began by treating the adventitial surface of the arterial
wall and ventricular muscle skirt with trypsin to open up
the matrix and allow diffusion of decellularization
reagents (Luo et al., 2014; Wilcox et al., 2005). Since
human aortic and pulmonary root walls are thinner than
porcine, initial studies investigated decellularization of
the arterial wall without trypsin and it was found that
simple scraping of the outer aortic and pulmonary root
wall to disrupt the adventitia was sufﬁcient for
decellularization of the full thickness of the arterial walls.
The scraped aortic and pulmonary roots were subject to
washes in hypotonic buffer and 0.1% (w/v) SDS in
hypotonic buffer to lyse the cells, solubilize the cell
membranes and disrupt protein/lipid and protein–protein
interactions in the presence of protease inhibitors to
prevent enzymatic damage to the structural proteins of
the ECM. The roots were then treated with nuclease to
cleave the nucleic acids followed by extensive washing
in hypertonic buffer and physiological buffer to remove
cellular fragments and wash out the SDS.
It was initially found that washing the valved roots
using this process was not completely successful with
residual DNA (circa 40–50%) remaining within the
junctional regions and the leaﬂets. It was observed that
the roots were collapsing in on themselves during the
washing process and it was clear that wash solutions were
not gaining access to the leaﬂets and leaﬂet junctional
regions during the decellularization process.
Subsequently, all valved roots were decellularized with
the lumen maintained open via the use of sutures to
suspend the roots from the container. This allowed the
Figure 6. Semiquantitative histopathological analysis of explanted cellular and decellularized aortic and pulmonary valve tissues following 12 weeks subcutaneous implantation
in mice. (a) Semiquantitative analysis of aortic valve tissues (b) Semiquantitative analysis of pulmonary valve tissues. Numbers of polymorphonuclear leucocytes (PMNs), lymphocytes
(Lym) and macrophages (Mac) were graded on a scale of 0–4 where 0 (no cells); 1 (rare cells 1–5); 2 (5–10 cells); 3 (heavy cells) and 4 (packed cells) per 1600 μm
2
. Cellular ingrowth
and calciﬁcation were graded on a scale 0–4 where 0 (none); 1 (slight); 2 (marked), 3 (moderate) and 4 (severe) over the whole of the explant. Data are presented as the mean (n = 4
explants) ± SD. (c) Average thickness of capsule surrounding explanted tissues. Data are presented as the mean (n = 4 explants) ± SD. Data for cellular and decellularized wall explants
were compared using Student t test which revealed a signiﬁcant difference between explanted cellular and decellularized aortic wall tissue but not explanted cellular and decellularized
pulmonary wall tissue. CAW, cellular aortic wall; DAW, decellularized aortic wall; DAL, decellularized aortic leaﬂet; CPW, cellular pulmonary wall; DPW, decellularized pulmonary wall;
DPL; decellularized pulmonary leaﬂet
Table 4. Mean maximum load of cardiac valve tissues before and after
decellularization
Tissue specimens Number of
samples tested
Mean maximum
load ± 95% CL
Axial wall samples Cellular aortic 8 6.91 ± 1.95
Decellularized aortic 4 8.31 ± 4.76
Cellular pulmonary 4 5.19 ± 1.49
Decellularized pulmonary 4 3.28 ± 1.38*
Circumferential wall
samples
Cellular aortic 8 15.30 ± 7.14
Decellularized aortic 4 16.00 ± 4.29
Cellular pulmonary 4 7.94 ± 6.85
Decellularized pulmonary 4 6.89 ± 1.73
Radial leaﬂet samples Cellular aortic 8 0.47 ± 0.35
Decellularized aortic 4 0.84 ± 0.11
Cellular pulmonary 4 0.36 ± 0.15
Decellularized pulmonary 4 0.12 ± 0.05*
Circumferential leaﬂet
samples
Cellular aortic 8 6.25 ± 0.89
Decellularized aortic 4 8.56 ± 3.08*
Cellular pulmonary 4 2.56 ± 2.52
Decellularized pulmonary 4 3.63 ± 1.10
Data are presented as the mean (n = 4 or 8) ± 95% CL. Comparisons between cellular
and decellularized samples for the same tissue type were made using Student t test.
*indicates signiﬁcant difference (p < 0.05).
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wash solutions to move backwards and forwards through
the lumen during agitation resulting in successful
decellularization of all regions of the valved roots.
The human donor valved roots were decellularized
using aseptic technique and sterile solutions throughout.
The decision to adopt this approach was based on
preliminary studies that showed that treatment of the
decellularized valves with peracetic acid ablated collagen
IV immunostaining in the basement membrane, and
knowledge that irradiation sterilization is not considered
appropriate for valve allografts due to the potential for
causing deterioration in ECM properties and clinical
performance (Helder et al., 2016; Sarathchandra et al.,
2012). Until a reliable sterilization process that does not
adversely affect the ECM is demonstrated for biological
tissue grafts, it remains acceptable to adopt aseptic
production for human tissue products. The wash solutions
from several decellularization runs were assessed for
microbial contamination by aseptically ﬁltering the
solutions onto 0.2-μm pore sized membranes followed by
culture of the membranes on microbiological plates. These
were consistently shown to be free of microbial growth.
During the course of these studies the nuclease was
changed from Pulmozyme to Benzonase for reasons of
economy and utility in a good manufacturing practices
manufacturing process. The ﬁnal concentration of
Benzonase to achieve the required reduction in total
DNA content (<15 ng/ml) was determined using human
donor cryopreserved aortas in a related project. The use
of this concentration (10 U/ml) of Benzonase was then
directly compared with the use Pulmozyme on porcine
pulmonary valved conduits and shown to give slightly
better results overall (Pulmozyme: leaﬂet; 47.9; wall 8.6;
junction 14.7; muscle 11.1 ng/mg DNA vs. Benzonase:
leaﬂet 13.4; wall 11.2; junction 8.15; muscle 1.7 ng/mg
DNA). It was not deemed necessary to use additional
human donor valves to repeat assays, once the change of
nuclease had been made.
The Badylak group (Crapo et al., 2011) have suggested
criteria (DNA content and lack of visible nuclear material
in tissue sections stained with H&E or DAPI) by which a
tissue can be judged decellularized based upon studies in
which an in vivo constructive remodelling response has
been observed. Following decellularization, no evidence
of cells, cellular remnants or nuclear material were
present in histological sections of the aortic or pulmonary
valve tissues and there was no evidence of overt damage
to the ECM, as judged by low-resolution light microscopy.
Fenestrations were often observed in the leaﬂets;
however, these are known to be present in cellular valves.
The ECM of the decellularized pulmonary arterial wall
and leaﬂets appeared to have a more open, porous
structure compared to cellular tissue.
There are limitations of using light microscopy to assess
cellular removal and matrix integrity. Alternative imaging
methods such as transmission electron microscopy (TEM)
can be used to analyse the tissues at higher resolution.
However, TEM analysis of the three-dimensional volume
of cardiac valve conduits was considered impractical. In
our previous studies of porcine cardiac valved conduits,
there was good agreement between the interpretation of
light microscopy and TEM analysis of decellularized
tissues (Luo et al., 2014).
Immunohistochemical analysis was carried out to
assess the retention or loss of ECM and membrane
proteins. This included analysis for collagen IV, which
was used as a marker for the basement membrane, which
is believed to be important for endothelialization (Herbst
et al., 1988) and VWF, which could potentially have the
undesirable effect of increasing platelet adhesion to the
decellularized matrix if in direct blood contact. Both
collagen IV and VWF were present in the decellularized
tissues. The retention of collagen IV was considered
important since this may encourage endothelialization
in vivo and mask the underlying thrombogenic matrix.
Matrix proteins ﬁbronectin and laminin were assessed
since these are important in facilitating cell adhesion
and differentiation and both were reduced, but still
present postdecellularization, which may indicate
minimal impact upon the constructive remodelling of
the decellularized tissues in vivo. There was an absence
of MHC Class 1 immunoreactivity in the decellularized
pulmonary valve tissues with only residual staining in
the aortic valve tissues, indicating a reduction in the
antigenicity of the decellularized tissues. Chondroitin
sulfate was assessed since it is the dominant GAG in the
proteoglycans in cardiac valve tissue (Rothenburger
et al., 2002) and showed a qualitative reduction in GAG
content postdecellularization. This ﬁnding was supported
by the quantitative analysis of sulfated sugars (GAGs)
which showed that only 25–26% of the original GAGs
remained in the valve leaﬂets following decellularization.
Removal of GAGs during decellularization processes
incorporating SDS has been reported previously (Luo
et al., 2014) and was therefore not unexpected. GAGs
are a major component of the spongiosa of cardiac valve
leaﬂets, providing hydration and interactions with the
ﬁbrous ECM and have been reported to provide a
damping mechanism for leaﬂets during systolic ﬂow
(Eckert et al., 2013). It is therefore important to
determine the effects of the GAG loss on the
hydrodynamic performance of the decellularized cardiac
valves. Our previous studies of decellularized porcine
valved conduits have shown a similar loss of GAGs with
no effect on the valve performance in hydrodynamic tests
(Luo et al., 2014). The loss of GAGs and cellular elements
in the decellularized valve leaﬂet tissues would account
for the apparent increase in collagen content per weight
of dried tissue compared to cellular tissue.
Importantly, the decellularization process had
essentially removed all but residual DNA from the
tissues with <10 ng/mg for all tissue regions with the
exception of the pulmonary valve leaﬂets. It should be
noted that estimation of the DNA content of successfully
decellularized tissues is problematic. In order to extract
measurable amounts of DNA, the initial mass of the
tissue required for extraction is 10-fold higher than that
required for cellular tissue. For the decellularized
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pulmonary valve leaﬂets the total mass of tissue from
each of the decellularized valves was only 30–100 mg
and the levels of DNA extracted were at the limits of
detection of the nano-spectrophotomer. Hence the data
for the estimation of DNA content of decellularized
pulmonary leaﬂets were not reliable and this was a
limitation of the study.
It is of interest to compare our decellularization process
to others applied to human donor cardiac valves that have
been used clinically. The Synergraft process uses
hypotonic cell lysis, nuclease digestion and isotonic
washes but does not incorporate a detergent wash
(Gerson et al., 2012; O’Brien et al., 1999; Zehr et al.,
2005). The process has, however, been reported to reduce
MHC immunoreactivity markedly, indicating reduction in
membrane proteins (Elkins et al., 2001b). The process
described by da Costa et al. (2010) uses 0.1% (w/v) SDS
and washing in isotonic Ringer lactate, but does not
mention the use of nuclease and the process described
by the Haverich group (Cebotari et al., 2011; Neumann
et al., 2014) incorporates a harsher detergent treatment
(0.5% w/v SDS plus 0.5% w/v sodium deoxycholate) but
again does not appear to incorporate a nuclease treatment
(Cebotari et al., 2011). Despite the fact that these
decellularized human donor cardiac valves have been
implanted into patients now for several years, details of
the DNA levels in these decellularized human donor valve
allografts is lacking. This is surprising given that DNA
levels are a good indicator of the degree of cell removal
(Crapo et al., 2011) and the potential role of residual
cellular DNA in calciﬁcation of tissue heart valve
substitutes (Schoen and Levy, 2005). To our knowledge
this is ﬁrst report of a decellularization process that
removes over 97% of the DNA from the junctional region
of human aortic and pulmonary valve conduits. In our
experience with porcine valves these regions are the most
resistant to decellularization.
The decellularized tissues were not toxic to cells in vitro
using standard extract and cytotoxicity tests. Hence
studies progressed to evaluate the biocompatibility of
the decellularized tissues in vivo using an established
mouse subcutaneous implant model which has been
previously shown to be an excellent indicator of the
propensity of tissues for calciﬁcation (Mirsadraee et al.,
2007). Initial studies indicated that the decellularized
aortic and pulmonary leaﬂet and wall tissues showed
evidence of tissue integration and recolonization by host
cells; however, a proportion of the samples revealed
evidence of foci of calciﬁcation. Further study revealed
the presence of calcium deposits in the decellularized
tissues prior to implantation in the mouse model and this
explained the result. Since the tissues investigated were
from donors with a mean age of 58, the study was
repeated using heart valves from younger donors. The
repeat study indicated biocompatibility of the
decellularized aortic and pulmonary wall and leaﬂet
tissues in the mouse model in comparison to
encapsulation and calciﬁcation of the cellular tissues from
the arterial walls of the same donor valves. Interestingly,
there was little evidence of a speciﬁc immune component
to either the cellular or decellularized tissues with the
response to both types of tissue orchestrated by
macrophages. The role of macrophages in the
regeneration of acellular biological scaffolds has been well
documented by ourselves and others (Brown et al., 2012;
Paniagua Gutierrez et al., 2015) and hence this was not
unexpected. There was clearly a different outcome for
the cellular compared to the decellularized tissue in the
mouse model with limited cellular inﬁltration into the
cellular tissue together with dystrophic calciﬁcation
presumably due to presence of dead cells and cellular
inﬁltration into the central areas of the decellularized
tissue in the absence of tissue degradation or necrosis. It
is important to note that the mouse model, although
useful for assessment of biocompatibility is not a
functional model for cardiac valve tissue.
Uniaxial tensile testing of the cellular and decellularized
aortic and pulmonary valve tissues was used to determine
the maximum load to failure. Here we chose to analyse the
mechanics based on force rather than stress, to avoid
recording changes due to changes in tissue thickness and
to make the results more relevant to the clinical
application. This showed a high degree of variation in both
the cellular and decellularized tissues, as might be
expected with human donor valves. Overall, the data
indicated that the decellularization process produced
moderate effects on the strength of the valve arterial and
leaﬂet tissues. A full biomechanical and haemodynamic
performance analysis of the decellularized valves has been
undertaken and will be reported elsewhere.
There are obvious limitations to this study, not least the
low number of replicate valves used for the various
analyses and the high degree of variation in the
quantitative data presented. However, the study used
human donor tissue, which unlike porcine tissue is not
readily available and hence the high degree of
variability reﬂected the variation in the donated tissues
in terms of age, sex and also lifestyle of the individual
donors.
In conclusion, a process for the decellularization of
human donor aortic and pulmonary cardiac valved
conduits has been developed which has been shown to
produce biocompatible grafts with virtually no DNA and
acceptable bulk biomechanical properties. The process
will now be translated to a good manufacturing
practices-compatible process for donor valves. However,
valves from younger donors may be preferable for
processing in order to avoid premature calciﬁcation.
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